Accelerate Diagnostics Annual Income Statement (NASDAQ:AXDX)

Add to My Stocks
$24.45 $0.25 (1.03%) AXDX stock closing price Feb 22, 2017 (Closing)

Fundamental analysis of AXDX stock involves analyzing its financial statements, apart from checking the Accelerate Diagnostics stock price In the income statement, an investor can look at important parameters like revenue, gross profits, net profits, and EPS basic to gain deeper insights. The income statement is generated for a specific period of time. The revenue increase of $0.14M for 2015 impacts the AXDX stock. Investors typically check year over year or quarter over quarter revenue growth. Along with Accelerate Diagnostics assets and Accelerate Diagnostics free cash flow, profits as shown in profit and loss statement give key insights about the business. The profits have decreased from $-30.93M YoY and 2015 revenue is $0.14M. Accelerate Diagnostics revenue for 2015 is $0.14M. View revenue and profit details for latest and last 10 financial years.

show more
Annual
Quarterly
View Previous Years
View Next Years
Fiscal year is Jan - Dec. 2015 2014 2013 2012 2011 2010 2009 2008 2007
Accelerate Diagnostics Net Sales or Revenues
0.14M0.12M0.04M-1.12M2.24M1.26M0.47M0.18M
Cost Of Goods Sold (COGS)-------0.01M0.05M
Accelerate Diagnostics Gross Profit
0.14M0.12M0.04M-1.12M2.24M1.26M0.46M0.12M
Research & Development Expense26.02M20.05M10.67M-0.45M0.5M0.74M0.88M0.99M
Selling General & Admin Expense17.88M10.69M4.31M-0.81M0.87M0.93M1.01M0.93M
Income Before Depreciation Depletion Amortization-43.75M-30.62M-14.93M--0.15M0.87M-0.4M-1.43M-1.8M
Depreciation Depletion Amortization1.79M0.89M0.37M-0.25M0.26M0.27M0.29M0.31M
Non Operating Income0.07M0.06M0.02M-0.03M0.02M-0.03M0.04M0.19M
Interest Expense0.02M0.01M-------
Accelerate Diagnostics Pretax Income
-45.49M-31.46M-15.28M--0.37M0.64M-0.71M-1.68M-1.92M
Provision for Income Taxes--0.52M-------
Minority Interest---------
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations-45.49M-30.93M-15.28M--0.37M0.64M-0.71M-1.68M-1.92M
Extraordinary Items & Discontinued Operations---------
Accelerate Diagnostics Net Income (Profit/Loss)
-45.49M-30.93M-15.28M--0.37M0.64M-0.71M-1.68M-1.92M
Average Shares used to compute Diluted EPS45M43.63M37.5M12.43M10.79M10.41M10.23M10.06M10.11M
Average Shares used to compute Basic EPS45M43.63M37.5M12.43M10.79M10.41M10.23M10.06M10.11M
Income Before Nonrecurring Items-45.5M-30.93M-15.28M-5.31M-0.38M0.64M-0.71M-1.68M-1.92M
Income from Nonrecurring Items---------
Accelerate Diagnostics Earnings Per Share Basic Net
-1.01-0.71-0.41-0.43-0.040.06-0.07-0.17-0.19
Accelerate Diagnostics Earnings Per Share Diluted Net
-1.01-0.71-0.41-0.43-0.040.06-0.07-0.17-0.19
EPS Diluted Before Nonrecurring Items-1.01-0.71-0.41-0.43-0.040.06-0.07-0.17-0.19
Preferred Dividends Acc Pd---------
Dividends Common---------
Dividend Per Share Common---------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Income statement for another ticker

1:25
AXDX
Before investing one should read a report on Accelerate Diagnostics stock analysis. It helps to look at the following income statement items:
  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth (See: Accelerate Diagnostics revenue chart) implies that the company is growing, which has been the case with Accelerate Diagnostics. One must stay away from stocks whose revenues are declining.
  • Bottom line: Most businesses like Accelerate Diagnostics try to improve their bottom line by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Accelerate Diagnostics historical stock prices to check how the price has moved with time. .

Accelerate Diagnostics Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
)
5694.6273
Operating margin
-87050
Net profit margin
-86500
Dividend yield
0%